The COVID-19 pandemic exposed the global supply chain for its weaknesses, and manufacturers of all sizes continued to be impacted by supply disruptions through most of 2022. Finally, we're beginning to see signs that the supply chain is on the mend, at least for most of the larger medtech companies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,